Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 15Terminated 4Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 9Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Mantle-Cell 5Glioblastoma 5Lymphoma, Non-Hodgkin 4Astrocytoma 4Oligodendroglioma 3Multiple Myeloma 3Gliosarcoma 3Central Nervous System Neoplasms 3Brain Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Large-Cell, Immunoblastic 2Hodgkin Disease 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Glioma 1Ependymoma 1

Interventions

Temozolomide 16Radiotherapy 7apatinib 5anlotinib 3Surgical Procedures, Operative 3Chlorotoxin 3Bevacizumab 3Aminolevulinic Acid 3Positron Emission Tomography Computed Tomography 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Lomustine 2Irinotecan 2Immunotherapy, Adoptive 2Blood Specimen Collection 2vandetanib 1sodium thiosulfate 1ribociclib 1poly ICLC 1lonafarnib 1lentiviral minigene vaccine of COVID-19 coronavirus 1etoposide phosphate 1Vinblastine 1Valproic Acid 1Tranexamic Acid 1Surveys and Questionnaires 1Sunitinib 1Rivaroxaban 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioma × Carmustine × Clear all
NCT00283543 2007-10-31

Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma

Kentuckiana Cancer Institute

Phase 2 Unknown
40 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡